Chemotherapy of advanced ovarian adenocarcinoma: A randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 23 (1) , 1-13
- https://doi.org/10.1016/0090-8258(86)90109-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- CHLORAMBUCIL-INDUCED CHROMOSOME DAMAGE TO HUMAN LYMPHOCYTES IS DOSE-DEPENDENT AND CUMULATIVEThe Lancet, 1984
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982
- Epithelial Carcinoma of the Ovary: Current StrategiesAnnals of Internal Medicine, 1981
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCERThe Lancet, 1976
- Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideGynecologic Oncology, 1974